| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| OEM(元) | 72,903,192.37 | 164,863,757.26 | 73,533,733.49 |
| 电生理(元) | 245,601,375.51 | 440,030,814.80 | 223,317,589.50 |
| 非血管介入类(元) | 22,838,199.44 | 38,521,826.76 | 16,350,926.25 |
| 冠脉通路类(元) | 654,284,608.47 | 1,054,493,577.41 | 503,229,514.24 |
| 外周介入类(元) | 212,577,731.99 | 351,275,868.48 | 175,211,576.07 |
| 营业成本(元) | |||
| OEM(元) | 28,264,319.70 | 60,964,630.90 | 28,561,255.07 |
| 电生理(元) | 61,087,007.91 | 115,479,725.81 | 57,967,836.68 |
| 非血管介入类(元) | 8,746,166.70 | 15,450,073.87 | 7,110,507.43 |
| 冠脉通路类(元) | 170,962,959.57 | 282,446,145.79 | 129,833,050.63 |
| 外周介入类(元) | 48,581,600.00 | 84,786,242.50 | 42,157,367.56 |
| 毛利(元) | |||
| OEM(元) | 44,638,872.67 | 103,899,126.36 | 44,972,478.42 |
| 电生理(元) | 184,514,367.60 | 324,551,088.99 | 165,349,752.82 |
| 非血管介入类(元) | 14,092,032.74 | 23,071,752.89 | 9,240,418.82 |
| 冠脉通路类(元) | 483,321,648.90 | 772,047,431.62 | 373,396,463.61 |
| 外周介入类(元) | 163,996,131.99 | 266,489,625.98 | 133,054,208.51 |
| 毛利率(%) | |||
| OEM(%) | 61.23 | 63.02 | 61.16 |
| 电生理(%) | 75.13 | 73.76 | 74.04 |
| 非血管介入类(%) | 61.70 | 59.89 | 56.51 |
| 冠脉通路类(%) | 73.87 | 73.21 | 74.20 |
| 外周介入类(%) | 77.15 | 75.86 | 75.94 |
| 收入构成(%) | |||
| OEM(%) | 6.03 | 8.05 | 7.42 |
| 电生理(%) | 20.33 | 21.47 | 22.52 |
| 非血管介入类(%) | 1.89 | 1.88 | 1.65 |
| 冠脉通路类(%) | 54.15 | 51.46 | 50.75 |
| 外周介入类(%) | 17.59 | 17.14 | 17.67 |
| 毛利构成(%) | |||
| OEM(%) | 5.01 | 6.97 | 6.19 |
| 电生理(%) | 20.72 | 21.78 | 22.78 |
| 非血管介入类(%) | 1.58 | 1.55 | 1.27 |
| 冠脉通路类(%) | 54.27 | 51.81 | 51.43 |
| 外周介入类(%) | 18.41 | 17.88 | 18.33 |